The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy

Brain Dev. 2024 May;46(5):199-206. doi: 10.1016/j.braindev.2024.02.001. Epub 2024 Feb 22.

Abstract

Background: In Duchenne muscular dystrophy (DMD), the immune system cells (ISC) synthesize molecules to regulate inflammation, a process needed to regenerate muscle. The relationship between those molecules and the muscle injury is unknown. Monocytes belonging to ISC are regulated by omega-3 fatty acids (ω-3 LCPUFAs) in DMD, but whether those fatty acids influence other ISC like T-cells is unknown.

Objective: We analyzed the expression of the muscle regeneration markers (FOXP3 and AREG) in circulating leukocytes of DMD patients with different lower limb muscle functions and whether ω-3 LCPUFAs regulate the expression of those markers, and the populations of circulating T-cells, their intracellular cytokines, and disease progression (CD69 and CD49d) markers.

Methods: This placebo-controlled, double-blind, randomized study was conducted in DMD boys supplemented with ω-3 LCPUFAs (n = 18) or placebo (sunflower oil, n = 13) for six months. FOXP3 and AREG mRNA expression in leukocytes, immunophenotyping of T-cell populations, CD49d and CD69 markers, and intracellular cytokines in blood samples were analyzed at baseline and months 1, 2, 3, and 6 of supplementation.

Results: Patients with assisted ambulation expressed higher (P = 0.015) FOXP3 mRNA levels than ambulatory patients. The FOXP3 mRNA expression correlated (Rho = -0.526, P = 0.03) with the Vignos scale score at month six of supplementation with ω-3 LCPUFAs. CD49d + CD8 + T-cells population was lower (P = 0.037) in the ω -3 LCPUFAs group than placebo at month six of supplementation.

Conclusion: FOXP3 is highly expressed in circulating leukocytes of DMD patients with the worst muscle function. Omega-3 LCPUFAs might modulate the synthesis of the adhesion marker CD49d + CD8 + T-cells, but their plausible impact on FOXP3 needs more research.

Keywords: Amphiregulin; Duchenne muscular dystrophy; Forkhead box P3; Muscle injury; Omega-3 long-chain polyunsaturated fatty acids.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cytokines
  • Forkhead Transcription Factors / genetics
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Male
  • Muscle, Skeletal / metabolism
  • Muscles / metabolism
  • Muscular Dystrophy, Duchenne*
  • RNA, Messenger / metabolism
  • Regeneration

Substances

  • Cytokines
  • Forkhead Transcription Factors
  • RNA, Messenger
  • FOXP3 protein, human